TABLE 4.
DPPC 25°C
|
DPPC 45°C
|
|||||
---|---|---|---|---|---|---|
% of changes (Laurdan) | [Enf]H2O+air* (mM) | [Enf]H2O† mM | [Enf]/[Lip]ag‡ | [Enf]H2O+air* (mM) | [Enf]H2O† mM | [Enf]/[Lip]ag‡ |
10 | 10 | 0.9§ | 0.8 | 2.2 | 0.1§ | 0.02 |
20 | 13 | 1.2 | 1.1 | 3.6 | 0.3§ | 0.1 |
30 | 16 | 1.45 | 1.2 | 5.3 | 0.5§ | 0.2 |
40 | 18 | 1.6 | 1.3 | 7.3 | 0.7 | 0.3 |
50 | 20 | 1.8 | 1.4 | 9.6 | 0.9 | 0.4 |
60 | 22 | 2.0 | 1.5 | 12.3 | 1.1 | 0.6 |
70 | 25 | 2.3 | 1.6 | 15.9 | 1.4 | 0.7 |
80 | 28 | 2.5 | 1.7 | 20.9 | 1.9 | 1.0 |
90 | 32 | 2.9 | 1.9 | 29.3 | 2.7 | 1.3 |
[Enf]H2O+air is the concentration of enflurane that is not in interaction with the lipids in the lamellar phases.
[Enf]H2O was estimated from the [Enf](air+H2O) assuming that the partition coefficient of enflurane between air and water is ∼10 and that the air and the water volumes in the cuvette were similar.
[Enf]/[Lip]ag is the enflurane-to-lipid concentration ratio within the lamellar phases. These values are determined from the origin and the slope of the linear relationships plotted on Figs. 9 (25°C) and 10 (45°C), respectively.
The [Enf]H2O in bold are those that fall within the clinical concentration range.